0001493152-22-033241.txt : 20221122 0001493152-22-033241.hdr.sgml : 20221122 20221122080013 ACCESSION NUMBER: 0001493152-22-033241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221118 FILED AS OF DATE: 20221122 DATE AS OF CHANGE: 20221122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meckler Jeffrey A CENTRAL INDEX KEY: 0001506916 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 221407519 MAIL ADDRESS: STREET 1: 740 BROADWAY STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (646) 427-2727 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 4 1 ownership.xml X0306 4 2022-11-18 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001506916 Meckler Jeffrey A C/O INDAPTUS THERAPEUTICS, INC 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 1 1 0 0 CEO and Director Common stock 2022-11-18 2022-11-18 4 P 0 400 1.7637 A 65774 D Common stock 2022-11-21 2022-11-21 4 P 0 9600 1.90 A 75374 D /s/ Jeffrey Meckler 2022-11-22